JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M106660200 on September 4, 2001

J. Biol. Chem., Vol. 276, Issue 45, 42477-42484, November 9, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/45/42477    most recent
M106660200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amor, J. C.
Right arrow Articles by Kahn, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amor, J. C.
Right arrow Articles by Kahn, R. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structures of Yeast ARF2 and ARL1

DISTINCT ROLES FOR THE N TERMINUS IN THE STRUCTURE AND FUNCTION OF ARF FAMILY GTPases*

J. Carlos Amor, John R. Horton, Xinjun Zhu, Yi WangDagger , Cameron Sullards, Dagmar RingeDagger , Xiaodong Cheng, and Richard A. Kahn§

From the Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322-3050 and the Dagger  Department of Biochemistry and Chemistry, Rosenstiel Basic Medical Research Center, Brandeis University, Waltham, Massachusetts 02454

Received for publication, July 16, 2001, and in revised form, August 29, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Structures were determined by x-ray crystallography for two members of the ADP-ribosylation factor (ARF) family of regulatory GTPases, yeast ARF1 and ARL1, and were compared with previously determined structures of human ARF1 and ARF6. These analyses revealed an overall conserved fold but differences in primary sequence and length, particularly in an N-terminal loop, lead to differences in nucleotide and divalent metal binding. Packing of hydrophobic residues is central to the interplay between the N-terminal alpha -helix, switch I, and the interswitch region, which along with differences in surface electrostatics provide explanations for the different biophysical and biochemical properties of ARF and ARF-like proteins.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

ADP-ribosylation factor (ARF)1 and ARF-like (ARL) proteins comprise the ARF family within the Ras superfamily of regulatory GTPases. Members of this superfamily function as molecular nodes in signaling that can directly activate one or more enzymatic activities or coordinate the recruitment and assembly of more elaborate multisubunit complexes. The conformational changes that accompany the binding of GDP and GTP can lead directly to changes in the affinity of the GTPase for proteins, lipids, and membranes. For Ras superfamily members these conformational changes are centered in two functional regions, referred to as switch I (SW1) and switch II (SW2) (1). Members of the ARF family have an additional nucleotide-sensitive region, an extension at the N terminus and a covalently attached myristate that together work as a "myristoyl switch" to coordinate activation (GTP binding) with translocation onto a membrane (2). In addition to its role in membrane binding, there is also evidence that the N terminus may influence effector binding or activities (3, 4). Residues in SW1 and SW2 make direct contacts with effectors and GTPase-activating proteins (GAPs) in a variety of GTPases, including ARFs (5, 6). It has been proposed that the two switches in ARF may act to coordinate the binding and activities of two different proteins simultaneously, a GAP and an effector, to effectively coordinate recruitment of vesicle cargo and GTP hydrolysis (6). However, the N-terminal region (residues 1-17) of ARF have been shown to be sufficient to confer ARF activity and increased GTPase activity to an ARL protein despite the distance between the N terminus and switch or nucleotide binding region (3). These data highlight the complexity of interactions as well as the novel mechanisms of regulation of ARFs as compared with other members of the Ras superfamily.

The distinction between ARFs and ARLs is based on both sequence relatedness and function (7). There are six mammalian ARFs and more ARLs, while the yeast Saccharomyces cerevisiae has only two ARFs and two ARLs. ARFs all share at least 60% identity in primary sequence and are active as (i) co-factor in the cholera toxin-catalyzed ADP-ribosylation of Galpha s, (ii) direct activators or phospholipase D, and (iii) suppressors of lethality resulting from the deletion of the two yeast ARF genes. The biological roles of ARFs are central to many steps in vesicular traffic, particularly those involving the Golgi (8). In contrast, ARLs share 40-60% sequence identity with each other or with any ARF and lack each of the ARF activities described above (9). Much less is known about biological roles, protein effectors, or the importance of membrane-lipid interactions for the ARLs. That ARFs are essential and highly conserved throughout eukaryotic evolution is highlighted by the findings that at least one ARF has been found in every eukaryote tested (although not yet in any prokaryote) and that each one tested has demonstrated the ability to complement the arf1-rf2-double mutant in yeast.

Structures have been determined by x-ray crystallography of the two most divergent human ARFs, ARF1 and ARF6 (10, 11), and also for the ARF-like protein murine ARL3 (18). These structures have revealed the fundamental conservation of structure between ARFs and other members of the Ras superfamily in the six beta -strands at the core of the protein and surrounding helices. We report here structures of GDP-bound, S. cerevisiae ARF2 (ScARF2) and ARL1 (ScARL1), as determined by x-ray crystallography to 1.6 and 3.2 Å resolution, respectively. The structures of the two proteins show changes in and surrounding the N terminus. These differences give indications of how the diverse biochemical characteristics may be determined or mediated by the sequence and structure of the N terminus. In addition, comparison of surface electrostatics of the four ARF family members revealed surprisingly large differences that are discussed with respect to properties of each protein.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Protein Expression and Purification-- ScARF2 and ScARL1 were expressed in BL21(DE3) bacteria using the pET3C expression plasmid as described previously for other ARF proteins (12). Cells were grown to an A600 of 1.0 before protein expression was induced with isopropylthio-beta -D-galactoside (0.5 mM). Cells were harvested by centrifugation after ~12 h of growth at 37 °C. Cells were resuspended in 25 mM Tris, 50 mM NaCl, 1 mM MgCl2, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 50 µM GDP, pH 7.5 before lysis using a French press. Bacterial cell lysate was passed over a low substituted Q-Macro column (Bio-Rad; 100-ml bed volume) in the same buffer, and the flow-through was applied to a high substituted Q-Macro column (Bio-Rad; 50-ml bed volume). A linear gradient (50-350 mM NaCl, 500 ml) in lysis buffer was used to fractionate proteins. Pooled fractions were concentrated to 5 ml and loaded on a Sephacryl S-100 HR (Amersham Pharmacia Biotech; 60 cm, 300-ml bed volume) gel filtration column. Protein purity was determined by denaturing (SDS) polyacrylamide gel electrophoresis, and the pooled fractions were concentrated to a final concentration of 1 mM protein for storage at -80 °C.

Crystallization, Data Collection, Structure Determination, and Refinement-- Crystals of ScARF2 were grown by the hanging drop method combining equal volumes (2 µl) of the protein stock and mother liquor (20% polyethylene glycol 8000, 0.1 M cacodylate, pH 6.5) at room temperature. ScARF2 crystals grew as thin plates (0.3 × 0.06 × 0.02 mm3) from a central hub and had to be separated before vitrification in 30% polyethylene glycol 8000, 0.1 M cacodylate, pH 6.5 and 15% glycerol using liquid propane. ScARL1 crystals were also obtained by the hanging drop (20% polyethylene glycol 8000, 15% glycerol, 0.1 M Tris, pH 8.5). Statistics for the structure determination are shown in Table I. For ScARF2, data collection to better than 1.6 Å was performed at the Brookhaven National Laboratory X12b beam line (gamma  = 1.008 Å). One-degree oscillation frames were integrated with DENZO, then merged, and scaled with SCALEPACK from HKL (13). Initial phases for the structure factors were determined by molecular replacement with AMoRe (14) using HsARF1-GDP (10) as the search model. For both proteins the final model was established by successive rounds of structure building using O (15) and refinement with CNS (16) (Table I).

Mass Spectrometry-- Nucleotide bound to ScARF2 was released by the addition of ice-cold HClO4 to a final concentration of 0.5 M, incubation at 0 °C for 10 min, removal of precipitated protein by centrifugation, and neutralization of the supernatant by addition of <FR><NU>1</NU><DE>6</DE></FR> volume of 1 M K2HPO4, 0.5 M acetic acid and <FR><NU>1</NU><DE>6</DE></FR> volume of 3 M KOH at 0 °C. The solution of the extracted nucleotide was then exchanged into deionized water and lyophilized, and the residue was resuspended in a 20% propanol, 1% triethylamine, water mixture. All experiments were performed on a PE Sciex API 3000 triple-quadrupole mass spectrometer equipped with a turboionspray source. Product ion spectra were acquired to detect the (M - H)- ions of m/z 442.3 or 522.4. Data was acquired for a total of 1.7 min, thus each spectrum was the signal-averaged sum of ~100 scans. Precursor ion spectra were acquired to detect either m/z 79.0 or 150.0. Data was acquired for a total of either 2.5 or 5.0 min, respectively, thus each spectrum was the signal-averaged sum of 300 scans. Nitrogen was used to collisionally activate precursor ion decomposition.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

ScARF1 and ScARF2 are over 97% identical and share about 74% identity with mammalian orthologs, e.g. HsARF1 or HsARF6 (see Fig. 1A). ScARF1 and ScARF2 were each expressed in bacteria, purified to homogeneity, and crystallized as described under "Materials and Methods." Crystals of ScARF2 diffracted to higher resolution (1.6 Å) and the resultant structure provided details not seen in previous ARF structures. Comparisons between yeast (ScARF2) and human (HsARF1 (10) and HsARF6 (11)) structures provide insights into conserved features throughout this evolutionary distance. We have also crystallized and solved a structure for yeast ARL1 (ScARL1) at a lower resolution (3.2 Å). Data and model statistics for each new structure are shown in Table I. Because of the functional differences between ARFs and ARLs (9) and greater divergence in sequence (40-60% identity) the variations between the structures provide details of structural divergence of likely functional importance.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 1.   Secondary structure, sequence, and structural alignment of Arf proteins. A, alignments of the primary sequences of HsARF1 (Protein Sequence Database (PIR) entry A33283), ScARF2 (PIR A36367), ScARL1 (PIR S46035), and HsARF6 (PIR B23741) are based on the three-dimensional model of HsARF1. Numbering and the secondary structure scheme are relative to HsARF1, but to avoid ambiguity, every 10th residue is in green. The secondary structural fold is indicated by arrows for beta -strands and cylinders for alpha -helices. The coloring scheme is followed throughout Figs. 2 and 4-7. GDP binding sequences are shaded in cyan, regions of an average r.m.s.d. >0.5 Å are shaded in yellow, residues involved in the interplay between the N terminus, switch I, and the ISR are shaded in magenta. B, comparison by superposition of the Calpha trace of ScARF2, ScARL1, and HsARF1. HsARF1 is indicated in black, ScARF2 in red, and ScARL1 in orange. Note that the Calpha trace of even distant family members, such as ScARL1, is well maintained. The ISRs are indicated, and the GDP binding site is toward the front of the plane between SW1 and SW2. The bound GDP is represented as a ball-and-stick model, and the bound Mg2+ is represented as a colored sphere. No Mg2+ was detected bound to ScARL1. Substantial variations exist in the placement of alpha NT and the length of the loop L-Nt connecting the N-terminal helix and the first strand (toward the back of the plane) as well as the start and end of SW1 (top and bottom of arrow) and throughout SW2. alpha Ct, C-terminal alpha -helix.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Statistics for x-ray structures reported here
NCS, noncrystallographic symmetry.

The secondary structures of GDP-bound ScARF2, ScARL1, and HsARF1 are essentially conserved (see Fig. 1B); the topology includes seven beta -strands, six alpha -helices, and 12 connecting loops. Of these, the protein core is an invariant six-stranded beta -sheet surrounded by six alpha -helices. The seventh strand forms an edge to the core and corresponds to the functionally important SW1 region seen in regulatory GTPases (1). The N-terminal region of each protein is an alpha -helix (alpha Nt) wedged between the C-terminal helix alpha -E and loop L-2/3, which connects strands beta 2 and beta 3, also referred to as the interswitch region (ISR). The presence of alpha Nt is in contrast to the rather undefined secondary fold seen for the N-terminal sequence in the ARL3 model (18). SW2 corresponds to L-3/B and alpha B, where L-3/B is on the opposite side of the N-terminal region and alpha B is opposite the bound GDP. The nucleotide binding site is on the surface of the protein between alpha Nt and SW2 (Fig. 1B).

Bacterially Expressed ScARF2 Contains Either Bound GDP or GDP-3'-phosphate-- Higher affinity for GDP over GTP and lipid dependence on the binding of activating guanine nucleotides likely explain the presence of GDP in the nucleotide binding site of ARFs as purified from mammalian tissues or bacteria (17). GDP was well fit in the binding site of previous ARF structures and in both yeast proteins described here. But there remained clear, but unexplained, density at the 3' position of the ribose bound to ScARF2. Different orientations of the ribose were considered, but only a covalent modification at the 3' position could be fit well (see Fig. 2A). The presence of a modified GDP in the protein preparation used to produce the ScARF2 crystals was investigated using mass spectroscopy. The presence of GDP, with the predicted mass of 442 atomic mass units, was evident in the preparation as was the presence of a second species with a mass of 522 atomic mass units. The mass of the larger species was consistent with a modification to GDP that adds 80 atomic mass units and can be explained by an additional phosphate (HPO3). We estimate from the mass spectroscopy results and the electron density in the crystal structure that our preparation of ScARF2 has ~70% GDP and 30% GDP-3'-phosphate bound. This is the first modified nucleotide found on a regulatory GTPase as purified, although no biological significance can yet be ascribed to this observation.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Modified GDP and polyols bound to ScARF2 and additional interactions between GTPases and other molecules. A, omit map of GDP-3'-phosphate. Mass spectrometry indicated the presence of a 3'-phosphate, which could be readily modeled; density of an omit map of the 3'-phosphate at 2.5 sigma  is in royal blue, of the GDP (excluding the 3'-PO4) in cyan at 3.0 sigma , and of the Mg2+ in green at 5.0 sigma . B, binding of polyols in a "channel" formed by the lower ISR, strands beta 2 and beta 3, in ScARF2. Due to the high resolution of the data (1.6 Å), a few and distinct variety of small molecules are found bound to the surface of ScARF2. In addition to water molecules, polyols such as glycerol and 1,3-propanediol, introduced by the use of glycerol as a cryoprotectant, are seen bound to the surface. A feature of the surface of ScARF2 is a channel or "cleft" between strands beta 2 and beta 3 in an area centered around SW1, the Mg2+ binding site, and SW2. Illustrated is a GRASP (25) model showing the electrostatic surface of ScARF2, indicating the presence and position of the channel as well as the glycerol, 1,3-propanediol, and GDP-3'-phosphate (GDP3'P) molecules (green), surrounded by the molecule VanderWaals radius model (yellow). The inset shows part of the protein residues affected and the location of the polyols in greater detail. The electron density, in royal blue, is an omit map of the polyols rendered at 2.75 s. The insert was generated with MOLSCRIPT (26).

The high resolution of the ScARF2 structure also allowed the definition of alternate conformations of side chains that were not evident in previous structures as well as the binding of a number of small molecules. For example, the invariant lysine (A2:K30),2 which contacts the alpha - and beta -phosphates, has alternate conformations for the gamma - and delta -carbons. Only one of these conformations is observed for all the ARF family members structures published to date, except the HsARF1·GDP·GAP structure (6), which has the other conformation. Our results show both conformations simultaneously present for Lys30 in ScARF2.

In addition to more than 200 water molecules, the surface of the protein was found to bind two glycerol, one 1,3-propanediol, nine 1,2-ethanediol, and three ethanol molecules per protein monomer, all introduced by the use of glycerol as cryoprotectant. The most provocative of the binding sites for these molecules is the channel extending from the nucleotide and magnesium binding site (Fig. 2B). The fact that this channel is lined by residues involved in magnesium binding (Glu54 and Asp67) and residues of the lower ISR (Asn52) as well as SW1 (Thr48 and Phe51) and SW2 (not shown) leads us to speculate a potential for this being a site of interaction with lipid, or other modulators, that could promote nucleotide exchange or conformational changes in one or both switches.

Homodimer Formation of ScARL1-- Similar to murine Arl3-GDP (18) a covalent homodimer was observed for ScARL1; however, here the disulfide bond is within the asymmetric unit and is linking the two Cys81 residues present in SW2 (Fig. 3). Dimerization was not the result solely of crystallization as it was detectible by either nondenaturing polyacrylamide gel electrophoresis or high-resolution gel filtration chromatography (results not shown) prior to crystallization. This is the only known example of a covalent homodimer being formed by a member of the Ras superfamily. Recently ARF1 and Ras were proposed to form homodimers on 3membranes (19, 20). Indeed membrane localization promotes dimer formation of Ras, which is essential, although not sufficient, for activation of its target molecule, Raf-1 (20). Dimerization also appears to be involved in the regulation of the activity of Rho family GTPases (21). To test the functional importance of dimerization we constructed the C81S mutant of ScARL1 and integrated it at the ARL1 locus by homologous recombination. This point mutant was fully functional as defined only by rescue of the cold sensitivity seen in arl1-cells. Thus, there is no evidence to support a required role for dimerization, covalent or otherwise, of ScARL1. However, both ARFs and ARLs have conserved cysteines; e.g. all known ARL1 orthologs have a cysteine at the position homologous to L1:81, while ARL2 orthologs lack that cysteine but have one at position 103 (A1:102).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Dimerization of ScARL1. A covalent dimer is seen as a result of a cystine bridge at Cys81 in SW2 of ScARL1. The Calpha traces of part of the SW2 region of the two separate molecules (indicated as ScARL1 A and ScARL1 B) are shown in green and magenta, respectively. The electron density in royal blue is of an omit map of Cys81 from each molecule rendered at 3.0 sigma . The distance between the sulfurs of the two cysteines, indicated in yellow, is modeled at 2.1 Å.

The model for ScARL1 reported here includes a disordered gap at residues 71-74 because of the lack of density to model the structure appropriately. This region is the start of SW2 and typically has the highest crystallographic thermal values in GTPase structures. In contrast, the structure of the entire SW2 region of ScARF2 is well defined and completely determined, possibly due to the crystal contacts present in this area. Similarly, the entire SW2 region of the ARL3 structure could be modeled (18).

Differences in Electrostatics between HsARF1, ScARF1, HsARF6, and ScARL1-- Comparison of the electrostatic surface of HsARF1, ScARF1, HsARF6, and ScARL1 revealed striking differences that are consistent with their membrane interactions. The electrostatic profiles of the four proteins fall into three categories: a patched surface, a primarily acidic surface potential, or a primarily basic surface potential (Fig. 4). HsARF1/ScARF2 comprise the group distinguished by the patched appearance of both anionic (negative potential in red) and cationic (positive potential in blue) areas as seen in Fig. 4, A and B. These patches of mixed charge, including SW1 and SW2, when positioning the N terminus toward the membrane, would provide a distinctive surface for protein interactions oriented toward the cytosol. Most prominent for HsARF1/ScARF2 is a horseshoe-shaped acidic cushion surrounding the N-terminal helix, which itself is predominantly basic (Fig. 4, A and B). Such a charged surface may assist in the orientation of the ARF1 to promote the interaction of the N terminus and the covalently bound myristate with membrane lipids. This may also help explain the ability of acidic lipids to promote nucleotide exchange through interaction with the N-terminal region (22).


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 4.   Electrostatic potential of ARF family proteins at ±kT/e as determined by GRASP (25). An electrostatic representation of HsARF1 (a), ScARF2 (b), ScARL1(c), and HsARF6 (d) with no bound nucleotide or Mg2+ was modeled by contouring the electrostatic isopotential at an energy of ±kT/e, where k is Boltzmann's constant, T is temperature, and e is the electron charge. Each of the four proteins are displayed in the same orientation, depicted using a ribbon diagram for HsARF1 in e. For ScARL1 some long chain residues on the surface such as glutamate and arginine or lysine were included even when no exact position could be established through the electron density. Areas of negative potential are shown in red (acidic residues), and areas of positive potential are shown in blue (basic residues). Hydrophobic areas are shown in gray. The differing size or volume of the potential, i.e. the distance from the edge of the electrostatic potential to the surface of the molecule, is due to differing charge densities. For example, comparison of ScARF2 to ScARL1 clearly indicates substantial differences in both charge composition and density. Note the consistent exposure of loop L-SW1/beta 2, the polar nature, and the directionality or sidedness of the electrostatic potential for the different molecules.

The surface of ScARL1 is distinguished by an overall negative electrostatic potential (see Fig. 4C). Like HsARF1, both human and yeast ARL1 are N-myristoylated, yet we have been unable to demonstrate4 any GTP-dependent binding of HsARL1 to membranes or lipid vesicles that is a hallmark of ARFs (23). These observations lead us to predict that the binding of human and yeast ARL1 to membrane is more dependent on protein-protein interactions at the membrane than is the binding of ARFs.

In contrast to the two profiles described above, the electrostatic potential of HsARF6 gives the protein a primarily cationic appearance (see Fig. 4D). Interestingly the location on the surface of HsARF6 that surrounds and includes the N-terminal helix is strongly basic. An increased tendency to interact with acidic head groups of lipids would be predicted from such an electrostatic profile, and this may contribute to the finding that ARF6 more tightly associates with membranes even when GDP is bound.

Despite the variation of the electrostatic potential for all four proteins as described above, there is one consistent observation among them. The highly conserved loop L-SW1/beta 2 is electrostatically isolated, both due to its exposure at the surface and its predominantly hydrophobic nature (especially noted for ScARL1 in Fig. 4C).

Structural Comparisons of the Four GTPases-- To identify structural differences between the four ARF family members, we aligned the structures of ScARF2, ScARL2, and HsARF6 against HsARF1. For an optimal alignment, one that would highlight the differences and maintain invariant features, we first superimposed the backbone Calpha -atoms of the highly invariant fourth, fifth, and sixth beta -strands. The r.m.s.d. for all Calpha -atoms was then calculated and plotted against the sequence position as shown in Fig. 5.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   r.m.s. deviation of the backbone Calpha of ScARF2, ScARL1, and HsARF6 relative to HsARF1. Calpha -atoms of beta -strands 4, 5, and 6 for ScARF2 (red), ScARL1(green), and HsARF6 (blue) were fitted against the Calpha -atoms in HsARF1 (Ref. 10, A molecule in PDB code 1HUR) of the equivalent beta -strands (gray box, beta 4 residues A1:G87-D93, beta 5 residues A1:A119-N126, and beta 6 residues A1:W153-T158). The average r.m.s.d. was calculated for this fitted region (ScARF2, 0.2 Å; ScARL1, 0.4 Å; HsARF6, 0.3 Å), and after this optimal fit, the Calpha r.m.s.d. for each residue in all three proteins was plotted in Å against residue number. Areas with gaps or insertions were excluded (black box, excluded residues 70-74 for all proteins; red box, nonmodeled residues 2-5 for ScARF2; blue box, gap for HsARF6; insertion of Ser15 for ScARL1, not indicated). To assist with correlations to the three-dimensional model, a cartoon of the secondary structure is shown below the graph. Fitting was performed using the McLachlan algorithm (27) as implemented in the program ProFit (28).

The largest differences were found at the N terminus (A1:2-19), the switch regions (SW1 = A1:36-52 and SW2 = A1:69-85), and the ISR (loop L-2/3, A1:57-62). Further prominent r.m.s. differences were found in regions A1:129-133 and A1:149-151. Amino acids 129-133 are adjacent to the highly conserved 126NKQD129 sequence, which is directly involved in the binding of the guanine nucleotide base. Residues 149-151 are close to the GAP binding site as described by Goldberg (6). Structural changes with a smaller r.m.s.d. were found in regions A1:100-120, at A1:27, and centered around A1:162 (see Fig. 5). Residues 100-120 are involved in binding to ARF-GAP (6). Residue 27 is part of the putative phosphate binding sequence GX4GK. Residue 162 follows a group of residues involved in binding the guanine base as discussed in more detail below. That these differences in structure are scattered throughout the molecules and are mostly located in previously identified regions essential to function are consistent with these being functionally important regions and useful in defining specificity between the proteins.

The Packing of a Hydrophobic Cluster, Made Up of Residues from the N Terminal Helix, SW1, and the Interswitch Region, Allows the N Terminus to Influence the Structure of SW1-- Membrane binding, nucleotide affinity, phospholipid dependence of GTP binding, and nucleotide hydrolysis by ARFs are all sensitive to the presence and sequence composition of the N-terminal 17 amino acids; they are the alpha Nt and loop (L-Nt) comprising the "N-terminal region" (3, 22). The structure and position of this region has only been determined for ARF(s) bound to GDP and is presumed to change dramatically upon binding GTP (5). How the presence or structure of the N-terminal region can so dramatically influence the nucleotide binding site has been the subject of much conjecture. A comparison of the four structures illustrates how the sequence of the N-terminal helix and the length of the following loop L-Nt can affect the structure of SW1 and the interswitch region and in so doing the nature of the nucleotide bound. In essence, the presence of the N-terminal region constrains the ISR (loop L-2/3), a primary determinant of the bound nucleotide. The largest differences detected from the comparison of the four structures were in these three elements: the N-terminal region, the ISR, and SW1. Differences in the N-terminal region (most obviously the lack of alpha Nt) and the ISR were also reported for the recent structure of ARL3 (18).

A more detailed comparison of these areas is shown in Fig. 6. A key to the organization of these regions is the presence of hydrophobic residues, best viewed in HsARF1 (Fig. 6A), which include Phe5, Phe9, Leu37, Leu39, Val56, Tyr58, Ile61, and Phe63, forming a hydrophobic cluster. Note, in particular, the extent to which Leu39 is inserted into the cluster and makes direct contact with the N-terminal helix. In HsARF6 (Fig. 6B) the equivalent is Leu35, but it is much less well fit into this cluster due to the shortening of loop L-Nt, a four-residue deletion relative to HsARF1 (Fig. 1A), and the presence of a leucine residue (Leu5) instead of a phenylalanine (Phe5), as in HsARF1(Fig. 6A). These changes lead to a reorientation of the ISR and specifically Tyr54. The result is a large change in the structure of the N-terminal portion of SW1 of HsARF6. In contrast, loop L-Nt is much longer in ScARL1, allowing yet other structural differences in the ISR. When coupled with the change to L1:I40 (corresponding to A1:L39) this allows the first part of SW1 to make closer contacts and additional hydrogen bonds with the ISR (Fig. 6C). Although ScARF2 (Fig. 6D) has a shorter loop L-Nt than HsARF1, the conserved Leu39 and hydrophobic cluster prevent the change in SW1 seen in HsARF6 and ScARL1. In ARL3, differences in the structure of the N terminus and ISR result from differences in key residues, e.g. a lysine instead of glutamate at position 54 and the two phenylalanines in ARF1, Phe5 and Phe9, are serine and lysine, respectively, in ARL3 (18). Thus, we conclude that the different packing of hydrophobic residues modified by contributions from the N-terminal helix and the ISR, in addition to the variation in length of loop L-Nt, lead to differences in the initial portion of SW1. The presence of this hydrophobic cluster, the degree of residue insertion, and the ability of backbone hydrogen bond formation are most likely the principal causes for the change in structure at the start of the SW1 region.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 6.   Variations in the alpha NT, ISR, and SW1 region. Residues in the N-terminal helix (magenta), loop L-Nt (green), and residues of L-2/3, the interswitch region (indigo) modify the secondary structure at the start of the switch I sequence (red). The yellow dashed line indicates backbone hydrogen bonds between SW1 and beta 2. The nucleotide and binding helix alpha A are in cyan. HsARF1 (a) and HsARF6 (b), without electron density, are shown for comparison. Omit maps of residues 38-45 for ScARL (c) and 37-44 for ScARF2 (d) were calculated and are shown in royal blue at 3.0 and 3.5 sigma , respectively. Note the variation in positioning of A1:L39 versus A2:L39 versus L1:I40 versus A6:L35 as well as the effect on the Calpha trace and the additional hydrogen bond between SW1 and beta 2 in ScARL1 (L1:E42-S58). In ScARL1 the length of loop L-Nt has an effect on the ISR by influencing the extent of the insertion of L1:I40 as well as allowing for the formation of new backbone hydrogen bonds. The anchoring of L1:I40, combined with the flip of its psi -angle (L1:I40: psi  = 165°, 0 = -136°; A1:L39: psi  = -7°, 0 = -94°), leads to a maximal repositioning by about 3 Å for the subsequent three residues (41) in this part (SW1) of ScARL1 relative to the equivalent HsARF1 residues (see a and c). The psi -angle flip between L1:I40 and L1:G41 also enables a new antiparallel hydrogen bond in the beta -strands between L1:E42(CO)-L1:S58(NH) (2.9 Å) and L1:V44(NH)-L1:T56(CO) (2.9 Å) (see c). A2:L39 is also buried in a hydrophobic cluster, but residues in the ISR and a substantial shortening of the N-terminal loop, concomitant with the repositioning of the N terminus itself, cause a displacement of the ISR toward the N terminus. This movement apparently abrogates the formation of a new hydrogen bond in the antiparallel beta -strands between A2:E41(CO)-A2:E57(NH) (4.9 Å), thereby preventing the flip of the psi -angle between A2:L39 and A2:G40. In this manner the residues around residue A2:L39 (d) maintain the same conformation seen in HsARF1. The presence in HsARF6 of a leucine at position 5, where the corresponding residue is a phenylalanine in the other three proteins, causes the N-terminal helix in this area to slightly unwind, effectively raising A6:L5 and with it A6:S6. This allows the ISR, particularly A6:Y54, to be positioned low against the N-terminal helix effectively shrinking the cluster created by A2:L5, -F9, -L33, -Y54, -V57, and -F59. This prevents A6:L35 from entering the cluster to the same degree as in the other proteins (see b). Repositioning of the ISR due to the shorter N-terminal loop and preventing A6:L35 from being buried effectively prevent the flip of the psi -angle of A6:L35, and no new hydrogen bonds between beta -strands can be established. These changes keep the beginning part of SW1 in ARF6 as much as 5 Å away from the positions seen in the other proteins. The figure was generated with MOLSCRIPT (26).

Differences in the Binding Sites for Magnesium and GDP-- Glutamate 50 of HsARF6 influences nucleotide exchange, probably through effects on the binding of Mg2+ (11). This glutamate (A6:E50, A1:E54) cannot approach the metal to make the contacts seen in ARF1 (see Ref. 10 and Fig. 7, A and B), and thus a weakening of the affinity for Mg2+ was predicted (11). We find similar structural variations in ScARL1 and ScARF2 that are also predicted to have an impact on the affinity for magnesium (Mg2+) and consequently nucleotides (Fig. 7, C and D). This may explain the observations that indicate each of these proteins exchange nucleotides more rapidly than HsARF1. It may also explain the absence of bound Mg2+ for some of the published structures (11, 18).


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 7.   Structural observations affecting residues involved in Mg2+ binding. Structurally equivalent residues in SW1 (A6:E50, A1:E54, L1:E55, and A2:E54), beta 2 (A6:S38, A1:I42, L1:V43, and A2:V42), and helix alpha A (A6:Y31, A1:Y35, L1:Y36, and A2:Y35) of HsARF6 (a), HsARF1 (b), ScARL1 (c), and ScARF2 (d), respectively, affect the ability of the glutamate in SW1 to interact with the magnesium ion. The variation in the X1-angle of the indicated tyrosine in alpha A in addition to changes in residues at the start of SW1 (see also Figs. 5 and 6, a-d) allow for the variation of distance between the tyrosine hydroxyl and the invariant glutamate in SW1 (yellow line). For HsARF6, A6:S38 is principally interacting with its A6:E50 (yellow line). The ability of the tyrosine to differentially hydrogen bond with the glutamate is hypothesized to interfere with the binding of the Mg2+ (shown in green when present), which in turn affects nucleotide affinity and exchange (GDP indicated as ball-and-stick model). The secondary structures are labeled and follow the color scheme given in Fig. 1A. The figure was generated with MOLSCRIPT (26).

The predicted differences in affinity for magnesium result from an increase in distance, i.e. decrease in interaction, between a conserved glutamate (A1:E54, L1:E55), involved in binding of the Mg2+, and a conserved tyrosine hydroxyl (A1:Y35, L1:Y36). This results from structural changes and sequence variations in the SW1 area, specifically at residues A1:40-42 (L1:41-43). In ScARL1 (Fig. 7C), the modified positioning of L1:I40, including the flip of its psi -angle, combines with the sequence difference of L1:V43 (A1:I42) to allow L1:Y36 (A1:Y35) to interact with L1:E55 (A1:E54). A 90° rotation around X1 of L1:Y36 in ScARL1 (from -172° in HsARF1 to -79° in ScARL1) enables the tyrosine hydroxyl to hydrogen bond with L1:E55 (3.0 Å) (see Fig. 7C), moving L1:E55 away from its position as an effective Mg2+ coordinator (10) (see Fig. 7B). The same rotation of A2:Y35 is observed in ScARF2 (X1 = -82°) as well as the presence of a valine at residue 42, but because the topology around SW1 is more similar to HsARF1, A2:Y31 cannot approach A2:E54 (5.0 Å) (see Fig. 7D). This trend is most exaggerated in ARF6. Again the same rotation of A6:Y31 is observed (X1 = -76°), but because of the topology divergence in SW1 around this area relative to HsARF1, A6:Y31 is even further from A6:E50 (8.0 Å) (Fig. 7A). Instead A6:E50 hydrogen bonds with A6:S38 (equivalent to residue A1:I42). Thus, the most dramatic repositioning of the conserved glutamate is found in HsARF6 (11) followed by ScARL1 and ScARF2, and the nearest approach of glutamate and magnesium is seen in HsARF1. Although the direct coordination of magnesium with this conserved glutamate was not seen in the other HsARF1 structure (24), all of these data are consistent with this glutamate playing a central role in the binding of magnesium to members of the ARF family and consequently to the affinity of guanine nucleotides. This argument was further supported by the recent ARL3-GDP model in which sequence variations in SW1, similar to those mentioned above, and the changes of both of the key residues (A1:E54 and A1:Y35) to lysine result in altered binding of magnesium. In the ARL3-GDP model no Mg2+ is evident but a SO<UP><SUB>4</SUB><SUP>2−</SUP></UP> is interacting with both these lysines, and GDP binding, but not GTP binding, is Mg2+-independent (18). Thus, a change in the binding of magnesium can result from either the replacement of the critical glutamate or its interaction with tyrosine, in each case resulting in the loss of a critical coordination of the magnesium.

Nucleotides bind to ARFs through interactions above and below the plane of the base. On one face are side chains from the second conserved G-domain, NKQD (A1:N126-D129) in the ARF family, and on the other face is a less conserved residue (A1:T161). Given the importance of these interactions and their conservation among GTPases it was surprising to note that after the N-terminal region, SW1, and SW2, the region with the highest r.m.s. deviation between structures (>1 Å) is found in loop L-5/D, A1:130LPNA133, immediately following A1:D129. A1:K127 (not shown) interacts hydrophobically along the face of the base while Asp129 forms a hydrogen bond at the edge of the base. While these interactions were conserved in all four structures the distances of the bonds formed and orientations of side chains differed in ways that may predict differences in nucleotide affinities or handling. Not only does the r.m.s. analysis (Fig. 5) show substantial differences between the backbones in this G-domain, the side chains are oriented differently as well. A change in the residue corresponding to A1:N132 is always coordinated with a concomitant change at residue A1:N95 (see Fig. 1A). These residues are on loops that interact with each other, and it is the type of interaction, which can vary with sequence changes, that causes the larger r.m.s. deviation at the location of loop L-5/D.

On the other side of the base is the less conserved sequence (A1:158TCAT161) that provides A1:T161 for base interactions, but this interaction appears much less strong. The density for A2:T161 indicates this residue is rotating through about 90°. It is also hydrogen bonding with a water molecule. The sequence at this position varies within the ARF family and can be a valine, isoleucine, leucine, or alanine in different ARLs. Structural variation at the guanine base sandwich due to A1:T161 and Asp129 (in turn due to structural perturbations in the subsequent loop residues 130-133) most likely influences the ability of the protein to bind the base of the nucleotide and therefore influences the affinity of the nucleotide, similar to differences in the binding of magnesium. A rank order in predicted affinity for GDP is difficult as it results from at least three factors that do not necessarily exert their effect in a coordinated fashion: the residue at position A1:T161, the proximity and mobility of residues A1:D129-L130, and the orientation of A1:N132 resulting from its interaction with A1:N95.

    Addendum

Another ARL structure, that of ARL2(GTP) bound to the delta  subunit of phosphodiesterase (PDEdelta ), was published during the review of this manuscript (29).

    FOOTNOTES

* This work was supported by National Institutes of Health Grant AI43996 (to J. C. A., X. Z., J. H., and R. A. K.) and the Georgia Research Alliance.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom all correspondence should be addressed: Dept. of Biochemistry, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322-3050. Tel.: 404-727-3561; Fax: 404-727-3746; E-mail: rkahn@emory.edu.

Published, JBC Papers in Press, September 4, 2001, DOI 10.1074/jbc.M106660200

2 In discussing comparisons between the four ARF family members we use the numbering for HsARF1 as the benchmark for this family. Residue numbering in HsARF1 (PDB code 1HUR) is indicated by the abbreviation A1:"residue," in ScARF2 as A2:residue, in ScARL1 as L1:residue, and in HsARF6 (PDB code 1E0S) as A6:residue. Single letter abbreviations are used for amino acids in this numbering scheme.

3 A. G. Rosenwald, M. Rhodes, H. Van Valkenburgh, G. Chapman, J. Shu, V. Palanivel, C. J. Testa, A. B. Boman, C. J. Zhang, and R. A. Kahn, submitted.

4 H. Van Valkenburgh, J. D. Sharer, and R. A. Kahn, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: ARF, ADP-ribosylation factor; ARL, ARF-like; GAP, GTPase activating protein; ISR, interswitch region; r.m.s., root mean square; r.m.s.d., root mean square deviation; SW1, switch I; and SW2, switch II; alpha Nt, N-terminal alpha -helix; L-Nt, N-terminal loop.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

1. Lacal, J. C., and McCormick, F. (1993) The Ras Superfamily of GTPases , CRC Press, Boca Raton, FL
2. Beraud-Dufour, S., and Balch, W. E. (2001) Methods Enzymol. 329, 245-247[Medline] [Order article via Infotrieve]
3. Kahn, R. A., Randazzo, P., Serafini, T., Weiss, O., Rulka, C., Clark, J., Amherdt, M., Roller, P., Orci, L., and Rothman, J. E. (1992) J. Biol. Chem. 267, 13039-13046[Abstract/Free Full Text]
4. Zhu, X., Boman, A. L., Kuai, J., Cieplak, W., and Kahn, R. A. (2000) J. Biol. Chem. 275, 13465-13475[Abstract/Free Full Text]
5. Goldberg, J. (1998) Cell 95, 237-248[CrossRef][Medline] [Order article via Infotrieve]
6. Goldberg, J. (1999) Cell 96, 893-902[CrossRef][Medline] [Order article via Infotrieve]
7. Clark, J., Moore, L., Krasinskas, A., Way, J., Battey, J., Tamkun, J., and Kahn, R. A. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8952-8956[Abstract/Free Full Text]
8. Roth, M. G. (1999) Trends Cell Biol. 9, 174-179[CrossRef][Medline] [Order article via Infotrieve]
9. Tamkun, J. W., Kahn, R. A., Kissinger, M., Brizuela, B. J., Rulka, C., Scott, M. P., and Kennison, J. A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 3120-3124[Abstract/Free Full Text]
10. Amor, J. C., Harrison, D. H., Kahn, R. A., and Ringe, D. (1994) Nature 372, 704-708[CrossRef][Medline] [Order article via Infotrieve]
11. Menetrey, J., Macia, E., Pasqualato, S., Franco, M., and Cherfils, J. (2000) Nat. Struct. Biol. 7, 466-469[CrossRef][Medline] [Order article via Infotrieve]
12. Kahn, R. A. (1991) Methods Enzymol. 195, 233-242[Medline] [Order article via Infotrieve]
13. Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326
14. Navaza, J. (1994) Acta Crystallogr. Sect. A 50, 157-163[CrossRef]
15. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. A 47, 110-119
16. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve]
17. Kahn, R. A., Goddard, C., and Newkirk, M. (1988) J. Biol. Chem. 263, 8282-8287[Abstract/Free Full Text]
18. Hillig, R. C., Hanzal-Bayer, M., Linari, M., Becker, J., Wittinghofer, A., and Renault, L. (2000) Structure 8, 1239-1245[Medline] [Order article via Infotrieve]
19. Zhao, L. Y., Helms, J. B., Brunner, J., and Wieland, F. T. (1999) J. Biol. Chem. 274, 14198-14203[Abstract/Free Full Text]
20. Inouye, K., Mizutani, S., Koide, H., and Kaziro, Y. (2000) J. Biol. Chem. 275, 3737-3740[Abstract/Free Full Text]
21. Zhang, B. L., and Zheng, Y. (1998) J. Biol. Chem. 273, 25728-25733[Abstract/Free Full Text]
22. Kahn, R. A., Terui, T., and Randazzo, P. A. (1996) J. Lipid Mediat. Cell Signal. 14, 209-214[CrossRef][Medline] [Order article via Infotrieve]
23. Kahn, R. A., and Gilman, A. G. (1986) J. Biol. Chem. 261, 7906-7911[Abstract/Free Full Text]
24. Greasley, S. E., Jhoti, H., Teahan, C., Solari, R., Fensome, A., Thomas, G. M. H., Cockcroft, S., and Bax, B. (1995) Nat. Struct. Biol. 2, 797-806[CrossRef][Medline] [Order article via Infotrieve]
25. Nicholls, A., Sharp, K., and Honig, B. (1991) Proteins Struct. Funct. Genet. 11, 281-296[CrossRef][Medline] [Order article via Infotrieve]
26. Esnouf, R. M. (1999) Acta Crystallogr. Sect. D Biol. Crystallogr. 55, 938-940[CrossRef][Medline] [Order article via Infotrieve]
27. McLachlan, A. D. (1982) Acta Crystallogr. Sect. A 38, 871-873[CrossRef]
28. Martin, A. C. R. (1998) Profit, version 1.8 , SciTech Softwarewww.bioinf.org.uk/software
29. Renault, L., Hanzal-Bayer, M., and Hillig, R. C. (2001) Acta Crystallogr. Sect. D Biol. Crystallogr. 57, 1167-1170[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Splingard, J. Menetrey, M. Perderiset, J. Cicolari, K. Regazzoni, F. Hamoudi, L. Cabanie, A. El Marjou, A. Wells, A. Houdusse, et al.
Biochemical and Structural Characterization of the Gem GTPase
J. Biol. Chem., January 19, 2007; 282(3): 1905 - 1915.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. D. Seidel III, J. C. Amor, R. A. Kahn, and J. H. Prestegard
Conformational Changes in Human Arf1 on Nucleotide Exchange and Deletion of Membrane-binding Elements
J. Biol. Chem., November 12, 2004; 279(46): 48307 - 48318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Hill, Y. Li, M. Bennett, M. McKay, X. Zhu, J. Shern, E. Torre, J. J. Lah, A. I. Levey, and R. A. Kahn
Munc18 Interacting Proteins: ADP-RIBOSYLATION FACTOR-DEPENDENT COAT PROTEINS THAT REGULATE THE TRAFFIC OF {beta}-ALZHEIMER'S PRECURSOR PROTEIN
J. Biol. Chem., September 19, 2003; 278(38): 36032 - 36040.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Grayson, F. Bartolini, J. P. Chapple, K. R. Willison, A. Bhamidipati, S. A. Lewis, P. J. Luthert, A. J. Hardcastle, N. J. Cowan, and M. E. Cheetham
Localization in the human retina of the X-linked retinitis pigmentosa protein RP2, its homologue cofactor C and the RP2 interacting protein Arl3
Hum. Mol. Genet., November 15, 2002; 11(24): 3065 - 3074.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Jochum, D. Jackson, H. Schwarz, R. Pipkorn, and B. Singer-Kruger
Yeast Ysl2p, Homologous to Sec7 Domain Guanine Nucleotide Exchange Factors, Functions in Endocytosis and Maintenance of Vacuole Integrity and Interacts with the Arf-Like Small GTPase Arl1p
Mol. Cell. Biol., July 1, 2002; 22(13): 4914 - 4928.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. S. Click, T. Stearns, and D. Botstein
Systematic Structure-Function Analysis of the Small GTPase Arf1 in Yeast
Mol. Biol. Cell, May 1, 2002; 13(5): 1652 - 1664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Bartolini, A. Bhamidipati, S. Thomas, U. Schwahn, S. A. Lewis, and N. J. Cowan
Functional Overlap between Retinitis Pigmentosa 2 Protein and the Tubulin-specific Chaperone Cofactor C
J. Biol. Chem., April 19, 2002; 277(17): 14629 - 14634.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. D. Sharer, J. F. Sh